Vectors TRIZ Cases

Engineered rAAV vectors incorporate miRNA binding sites to regulate MeCP2 expression levels in neural tissue.

Engineered introns resolve aberrant splicing to increase Fc fusion protein yields by 2.1-fold.

Engineered adeno-associated viral vectors utilize capsid mutations to achieve prolonged blood circulation and enhanced transduction efficiency.

A TRIP system represses transgene translation via RNA-binding protein binding to boost viral vector titers.

A hybrid promoter combines CMV enhancer and beta-actin elements to drive high target protein expression in eukaryotic cells.

Engineers combine Ad5 shafts with Ad3 knobs to target DSG2 receptors, resolving poor tumor transduction caused by low CAR expression.

Segmented prokaryotic signaling components function as orthogonal building blocks within mammalian cells, resolving crosstalk with endogenous pathways.

A multicistronic expression construct positions a hairpin RNA cassette within an intron to enable efficient transgene delivery.

Nested DNA sequences enable precise cell targeting by resolving the trade-off between circuit complexity and vector packaging capacity.

Genetically encoded reporters allow longitudinal tracking of cell fate and viability without invasive biopsies.

Recombinant adeno-associated virus vectors deliver synthetic nucleic acids encoding micro-dystrophin proteins to muscle cells.

An lncRNA expression construct augments regulatory B cell generation to enhance antigen-specific immune tolerance.

Extracting essential dystrophin domains fits the gene into AAV capsids, resolving packaging limits while up-regulating utrophin expression.

Low salt ion exchange chromatography enriches retroviral particles while preventing tonicity stress that reduces quality.

Removing LDLR receptors from packaging cells reduces autotransduction rates and cytotoxicity while increasing retroviral vector particle yield.

A mRNA molecule containing embedded RNA aptamers binds to immobilized affinity ligands on chromatography resins for targeted separation.

Segmented ZF6-DBD proteins silence mutant rhodopsin alleles via targeted promoter binding, reducing off-target effects and side effects.

A cationic lipid and polymer composite forms stable ribonucleoprotein complexes for cellular delivery.

Gamma satellite DNA sequences function as insulators that block heterochromatin spread, preventing epigenetic gene silencing in transgene constructs.

Mutant Cas9 proteins with specific amino acid substitutions maintain on-target cleavage efficiency.

Separate inducible promoter modules eliminate crosstalk and all-or-none effects to ensure correct protein folding.

Incorporating heterologous introns into expression vectors improves splicing efficiency and resolves low productivity bottlenecks in antibody manufacturing.

Placing cis elements downstream of the 3' LTR excludes packaging signals from proviral DNA, preventing aberrant splicing and transgene silencing.

Segmented expression vector cassettes modulate chain ratios to enhance immunoglobulin production while minimizing endoplasmic reticulum stress.

A synthetic transcription factor relay system directs reporter gene expression through a dedicated binding site.

Extended methylation-free CpG islands maintain transcriptionally active chromatin environments to increase transgene expression levels.

Targeted integration at the transferrin locus via homology-directed repair ensures stable Factor VIII expression, overcoming transient AAV delivery limitations.

Engineered HSV-1 deletes ICP34.5 and ICP47 genes to restrict replication in tumor cells while expressing FLT3L and IL12 for systemic immune activation.

Adeno-associated viral vectors deliver artificial microRNA constructs to inhibit target gene expression in cells.

Tandem promoter systems in engineered Pseudomonas strains coordinate enzyme expression to boost 3-HP titer while minimizing toxic intermediate accumulation.

Segmenting vector administration using non-sero-neutralizing envelope proteins overcomes humoral interference to sustain protective immunity.

Expressing the Qua-Quine Starch gene modifies biochemical composition, accelerating breeding cycles compared to conventional methods.

Engineered AAV capsids with specific n-mer inserts target cardiac muscle cells, reducing liver toxicity and improving transduction efficiency across species.

Mutant HSV glycoproteins bind alternative cell receptors, increasing entry efficiency and reducing required virus dose.

Fruit-specific promoters enable precise trait modification by directing transgene expression to target organs, bypassing lengthy traditional breeding cycles.

Segmented viral vectors deliver gas vesicle genes to primary cells, bypassing transfection limits.

Recombinant adeno-associated viral genomes encode telomerase reverse transcriptase driven by tissue-specific promoters for targeted gene delivery.

Engineered bacteria use inducible promoters to regulate essential gene expression based on local physiological cues.

A recombinant replication-defective herpes simplex virus vector enables single-infection production of adeno-associated viral particles.

Inner and outer surfactant layers prevent drug leakage and control particle size in water-soluble carriers.